The association between KRAS (KRAS Proto-Oncogene, GTPase) and Encephalocraniocutaneous Lipomatosis is well established and manually curated, with its 2 contributing sources — 2 of them expert-curated — recording pathogenic variants.
Sources2
Clinical variants6
Symptoms121
Compounds0
Trials0
Publications2
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.